Marimastat or No Further Therapy in Treating Women With Metastatic Breast Cancer That Is Responding or Stable Following Chemotherapy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- James N. Ingle, MD
Mayo Clinic
Study Chair - Joseph A. Sparano, MD
Albert Einstein College of Medicine
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ccop - Scottsdale Oncology Program
Scottsdale, Arizona, United States
- Robert H. Lurie Comprehensive Cancer Center, Northwestern University
Chicago, Illinois, United States
- Ccop - Carle Cancer Center
Urbana, Illinois, United States
- Ccop - Cedar Rapids Oncology Project
Cedar Rapids, Iowa, United States
- Ccop - Iowa Oncology Research Association
Des Moines, Iowa, United States
- Siouxland Hematology-Oncology
Sioux City, Iowa, United States
- Ccop - Wichita
Wichita, Kansas, United States
- Ccop - Duluth
Duluth, Minnesota, United States
- Mayo Clinic Cancer Center
Rochester, Minnesota, United States
- Centracare Clinic
Saint Cloud, Minnesota, United States
- Ccop - Missouri Valley Cancer Consortium
Omaha, Nebraska, United States
- Trinitas Hospital - Jersey Street Campus
Elizabeth, New Jersey, United States
- Hunterdon Regional Cancer Center
Flemington, New Jersey, United States
- Hackensack University Medical Center
Hackensack, New Jersey, United States
- Morristown Memorial Hospital
Morristown, New Jersey, United States
- Riverview Medical Center
Red Bank, New Jersey, United States
- St. Francis Medical Center
Trenton, New Jersey, United States
- Albert Einstein Comprehensive Cancer Center
The Bronx, New York, United States
- Medcenter One Health System
Bismarck, North Dakota, United States
- Altru Health Systems
Grand Forks, North Dakota, United States
- Ccop - Columbus
Columbus, Ohio, United States
- Ccop - Toledo Community Hospital Oncology Program
Toledo, Ohio, United States
- Hahnemann University Hospital
Philadelphia, Pennsylvania, United States
- Rapid City Regional Hospital
Rapid City, South Dakota, United States
- Ccop - Sioux Community Cancer Consortium
Sioux Falls, South Dakota, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 2 Dec 1997
- Primary completion
- 31 Dec 2004
- Completion
- —
- Last update posted
- 15 Jun 2023
- Registered enrollment
- 334
- Registry id
- NCT00003010
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.